InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.

Market Cap	$864.85M	P/E Ratio	NaN
52W High	$16.74	52W Low	$12.72
Div Yield	N/A	Payout Ratio	N/A
EPS Growth 3Y	4.1%	52W Position	23.1%
Overall Score	49	Value Score	80
Quality Score	50	Technical Score	18

EPS Current Est	$NA	EPS Next Est	$NA
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	INMD	$13.65	0.00%	893.04K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	INMD	$13.65	0%	893.04K
3
4
5
6

INMD

INMD

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get InMode Ltd. Data in Excel

Get InMode Ltd. Data in Excel